報價延遲最少15分鐘:2025/06/01 13:08 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.14 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.25/1.47
|
|
企業價值
829.17M
|
| 資產負債 |
|
每股賬面淨值
1.69
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
43.47M
|
|
每股收益
0.00
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/01 13:08 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States. |